{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:52:16Z","timestamp":1789501936496,"version":"build-2803163510"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Sao Paulo Research Foundation","award":["2012\/23796-2 and 2010\/12286-8"],"award-info":[{"award-number":["2012\/23796-2 and 2010\/12286-8"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00406-020-01096-0","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T13:02:50Z","timestamp":1580216570000},"page":"537-547","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["ACC Glu\/GABA ratio is decreased in euthymic bipolar disorder I patients: possible in vivo neurometabolite explanation for mood stabilization"],"prefix":"10.1007","volume":"271","author":[{"given":"Est\u00eav\u00e3o","family":"Scotti-Muzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais","family":"Chile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Fraccini","family":"Pastorello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia","family":"da Costa Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Henning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concepcion Garcia","family":"Otaduy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homero","family":"Vallada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcio Gerhardt","family":"Soeiro-de-Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,28]]},"reference":[{"key":"1096_CR1","unstructured":"Goodwin FK, Jamison KR (2007) Manic-depressive illness: bipolar and recurrent unipolar disorders, 2nd edn. Oxford University Press, New York"},{"issue":"Pt 23","key":"1096_CR2","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1113\/jphysiol.2011.216978","volume":"589","author":"CJ Stagg","year":"2011","unstructured":"Stagg CJ, Bestmann S, Constantinescu AO, Moreno LM, Allman C, Mekle R et al (2011) Relationship between physiological measures of excitability and levels of glutamate and GABA in the human motor cortex. J Physiol (Lond). 589(Pt 23):5845\u20135855","journal-title":"J Physiol (Lond)."},{"key":"1096_CR3","doi-asserted-by":"crossref","first-page":"649325","DOI":"10.1155\/2011\/649325","volume":"2011","author":"E Rossignol","year":"2011","unstructured":"Rossignol E (2011) Genetics and function of neocortical GABAergic interneurons in neurodevelopmental disorders. Neural Plast. 2011:649325","journal-title":"Neural Plast."},{"issue":"9","key":"1096_CR4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biopsych.2010.06.016","volume":"68","author":"C Y\u00fcksel","year":"2010","unstructured":"Y\u00fcksel C, Ongur D (2010) Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol Psychiatry. 68(9):785\u2013794","journal-title":"Biol Psychiatry."},{"issue":"4","key":"1096_CR5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/bdi.12074","volume":"15","author":"RO Brady","year":"2013","unstructured":"Brady RO, McCarthy JM, Prescot AP, Jensen JE, Cooper AJ, Cohen BM et al (2013) Brain gamma-aminobutyric acid (GABA) abnormalities in bipolar disorder. Bipolar Disord. 15(4):434\u2013439","journal-title":"Bipolar Disord."},{"issue":"11","key":"1096_CR6","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1176\/ajp.150.11.1731","volume":"150","author":"CA Altamura","year":"1993","unstructured":"Altamura CA, Mauri MC, Ferrara A, Moro AR, D'Andrea G, Zamberlan F (1993) Plasma and platelet excitatory amino acids in psychiatric disorders. Am J Psychiatry. 150(11):1731\u20131733","journal-title":"Am J Psychiatry."},{"issue":"2","key":"1096_CR7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/clinchem\/40.2.296","volume":"40","author":"F Petty","year":"1994","unstructured":"Petty F (1994) Plasma concentrations of gamma-aminobutyric acid (GABA) and mood disorders: a blood test for manic depressive disease? Clin Chem. 40(2):296\u2013302","journal-title":"Clin Chem."},{"key":"1096_CR8","doi-asserted-by":"crossref","unstructured":"Post RM, Ballenger JC, Hare TA, Goodwin FK, R LC, Jimerson DC et al (1980) Cerebrospinal fluid GABA in normals and patients with affective disorders. Brain Res Bull 5(Suppl. 2):755\u2013759","DOI":"10.1016\/0361-9230(80)90124-0"},{"issue":"12","key":"1096_CR9","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1176\/ajp.141.12.1533","volume":"141","author":"RH Gerner","year":"1984","unstructured":"Gerner RH, Fairbanks L, Anderson GM, Young JG, Scheinin M, Linnoila M et al (1984) CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls. Am J Psychiatry. 141(12):1533\u20131540","journal-title":"Am J Psychiatry."},{"issue":"5","key":"1096_CR10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1399-5618.2012.01033.x","volume":"14","author":"AD Gigante","year":"2012","unstructured":"Gigante AD, Bond DJ, Lafer B, Lam RW, Young LT, Yatham LN (2012) Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis. Bipolar Disord. 14(5):478\u2013487","journal-title":"Bipolar Disord."},{"issue":"2\u20133","key":"1096_CR11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pscychresns.2012.02.003","volume":"203","author":"NV Kraguljac","year":"2012","unstructured":"Kraguljac NV, Reid M, White D, Jones R, den Hollander J, Lowman D et al (2012) Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis. Psychiatry Res. 203(2\u20133):111\u2013125","journal-title":"Psychiatry Res."},{"key":"1096_CR12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fpsyt.2016.00061","volume":"7","author":"C Chiapponi","year":"2016","unstructured":"Chiapponi C, Piras F, Piras F, Caltagirone C, Spalletta G (2016) GABA system in schizophrenia and mood disorders: a mini review on third-generation imaging studies. Front Psychiatry. 7:61","journal-title":"Front Psychiatry."},{"issue":"10","key":"1096_CR13","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.biopsych.2016.05.005","volume":"81","author":"MS Lener","year":"2017","unstructured":"Lener MS, Niciu MJ, Ballard ED, Park M, Park LT, Nugent AC et al (2017) Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine. Biol Psychiatry. 81(10):886\u2013897","journal-title":"Biol Psychiatry."},{"issue":"5","key":"1096_CR14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","volume":"2","author":"JLR Rubenstein","year":"2003","unstructured":"Rubenstein JLR, Merzenich MM (2003) Model of autism: increased ratio of excitation\/inhibition in key neural systems. Genes Brain Behav. 2(5):255\u2013267","journal-title":"Genes Brain Behav."},{"issue":"4","key":"1096_CR15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10803-010-1065-0","volume":"41","author":"M Harada","year":"2011","unstructured":"Harada M, Taki MM, Nose A, Kubo H, Mori K, Nishitani H et al (2011) Non-invasive evaluation of the GABAergic\/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument. J Autism Dev Disord. 41(4):447\u2013454","journal-title":"J Autism Dev Disord."},{"issue":"1","key":"1096_CR16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/schbul\/sbu051","volume":"41","author":"A Anticevic","year":"2015","unstructured":"Anticevic A, Savic A, Repovs G, Yang G, McKay DR, Sprooten E et al (2015) Ventral anterior cingulate connectivity distinguished nonpsychotic bipolar illness from psychotic bipolar disorder and schizophrenia. Schizophr Bull. 41(1):133\u2013143","journal-title":"Schizophr Bull."},{"key":"1096_CR17","doi-asserted-by":"crossref","unstructured":"Soeiro de Souza MG, Otaduy MCG, Machado-Vieira R, Moreno RA, Nery FG, Leite C et al (2018) Anterior cingulate cortex glutamatergic metabolites and mood stabilizers in euthymic bipolar I disorder patients: a proton magnetic resonance spectroscopy study. Biol Psychiatry Cogn Neurosci Neuroimaging. https:\/\/doi.org\/10.1016\/j.bpsc.2018.02.007","DOI":"10.1016\/j.bpsc.2018.02.007"},{"key":"1096_CR18","doi-asserted-by":"crossref","unstructured":"Colla M, Schubert F, Bubner M, Heidenreich JO, Bajbouj M, Seifert F et al (2009) Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol. Mol Psychiatry 14(7):696\u2013704, 647","DOI":"10.1038\/mp.2008.26"},{"issue":"6","key":"1096_CR19","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.biopsych.2006.08.048","volume":"61","author":"Z Bhagwagar","year":"2007","unstructured":"Bhagwagar Z, Wylezinska M, Jezzard P, Evans J, Ashworth F, Sule A et al (2007) Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol Psychiatry. 61(6):806\u2013812","journal-title":"Biol Psychiatry."},{"issue":"3","key":"1096_CR20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pscychresns.2008.07.007","volume":"172","author":"R Senaratne","year":"2009","unstructured":"Senaratne R, Milne AM, MacQueen GM, Hall GBC (2009) Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy study. Psychiatry Res. 172(3):205\u2013209","journal-title":"Psychiatry Res."},{"issue":"2","key":"1096_CR21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pscychresns.2015.05.010","volume":"233","author":"A Ehrlich","year":"2015","unstructured":"Ehrlich A, Schubert F, Pehrs C, Gallinat J (2015) Alterations of cerebral glutamate in the euthymic state of patients with bipolar disorder. Psychiatry Res. 233(2):73\u201380","journal-title":"Psychiatry Res."},{"key":"1096_CR22","doi-asserted-by":"crossref","unstructured":"Soeiro de Souza MG, Henning A, Machado-Vieira R, Moreno RA, Pastorello BF, da Costa Leite C et al (2015) Anterior cingulate Glutamate-Glutamine cycle metabolites are altered in euthymic bipolar I disorder. Eur Neuropsychopharmacol 25(12):2221\u20132229","DOI":"10.1016\/j.euroneuro.2015.09.020"},{"issue":"2","key":"1096_CR23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3174\/ajnr.A2902","volume":"34","author":"LM Levy","year":"2013","unstructured":"Levy LM, Degnan AJ (2013) GABA-based evaluation of neurologic conditions: MR spectroscopy. AJNR Am J Neuroradiol. 34(2):259\u2013265","journal-title":"AJNR Am J Neuroradiol."},{"issue":"9","key":"1096_CR24","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/hbm.23244","volume":"37","author":"RR Sch\u00fcr","year":"2016","unstructured":"Sch\u00fcr RR, Draisma LWR, Wijnen JP, Boks MP, Koevoets MGJC, Jo\u00ebls M et al (2016) Brain GABA levels across psychiatric disorders: a systematic literature review and meta-analysis of (1) H-MRS studies. Hum Brain Mapp 37(9):3337\u20133352","journal-title":"Hum Brain Mapp"},{"issue":"18","key":"1096_CR25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1601-5215.2006.00132.x","volume":"2","author":"PW Wang","year":"2006","unstructured":"Wang PW, Sailasuta N, Chandler RA, Ketter TA (2006) Magnetic resonance spectroscopy measurement of cerebral gamma-aminobutyric acid concentrations in patients with bipolar disorders. Acta Neuropsychiatr 2(18):120\u2013126","journal-title":"Acta Neuropsychiatr"},{"issue":"3","key":"1096_CR26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.pnpbp.2008.12.025","volume":"33","author":"RE Kaufman","year":"2009","unstructured":"Kaufman RE, Ostacher MJ, Marks EH, Simon NM, Sachs GS, Jensen JE et al (2009) Brain GABA levels in patients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 33(3):427\u2013434","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"issue":"2","key":"1096_CR27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00213-013-3244-0","volume":"231","author":"BR Godlewska","year":"2014","unstructured":"Godlewska BR, Yip SW, Near J, Goodwin GM, Cowen PJ (2014) Cortical glutathione levels in young people with bipolar disorder: a pilot study using magnetic resonance spectroscopy. Psychopharmacology 231(2):327\u2013332","journal-title":"Psychopharmacology"},{"issue":"7","key":"1096_CR28","doi-asserted-by":"crossref","first-page":"e1163","DOI":"10.1038\/tp.2017.141","volume":"7","author":"JJ Prisciandaro","year":"2017","unstructured":"Prisciandaro JJ, Tolliver BK, Prescot AP, Brenner HM, Renshaw PF, Brown TR et al (2017) Unique prefrontal GABA and glutamate disturbances in co-occurring bipolar disorder and alcohol dependence. Transl Psychiatry. 7(7):e1163","journal-title":"Transl Psychiatry."},{"issue":"2","key":"1096_CR29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1601-5215.2006.00132.x","volume":"18","author":"PW Wang","year":"2006","unstructured":"Wang PW, Sailasuta N, Chandler RA, Ketter TA (2006) Magnetic resonance spectroscopic measurement of cerebral gamma-aminobutyric acid concentrations in patients with bipolar disorders. Acta Neuropsychiatr 18(2):120\u2013126","journal-title":"Acta Neuropsychiatr"},{"key":"1096_CR30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.nicl.2017.07.009","volume":"16","author":"TC Ford","year":"2017","unstructured":"Ford TC, Nibbs R, Crewther DP (2017) Increased glutamate\/GABA+ ratio in a shared autistic and schizotypal trait phenotype termed social disorganisation. Neuroimage Clin. 16:125\u2013131","journal-title":"Neuroimage Clin."},{"issue":"7","key":"1096_CR31","doi-asserted-by":"crossref","first-page":"e0181961","DOI":"10.1371\/journal.pone.0181961","volume":"12","author":"TC Ford","year":"2017","unstructured":"Ford TC, Nibbs R, Crewther DP (2017) Glutamate\/GABA+ ratio is associated with the psychosocial domain of autistic and schizotypal traits. PLoS ONE 12(7):e0181961","journal-title":"PLoS ONE"},{"issue":"3","key":"1096_CR32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0165-0173(91)90010-6","volume":"16","author":"R Anwyl","year":"1991","unstructured":"Anwyl R (1991) Modulation of vertebrate neuronal calcium channels by transmitters. Brain Res Brain Res Rev. 16(3):265\u2013281","journal-title":"Brain Res Brain Res Rev."},{"issue":"1","key":"1096_CR33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0896-6273(91)90077-D","volume":"7","author":"MG Erlander","year":"1991","unstructured":"Erlander MG, Tillakaratne NJ, Feldblum S, Patel N, Tobin AJ (1991) Two genes encode distinct glutamate decarboxylases. Neuron 7(1):91\u2013100","journal-title":"Neuron"},{"issue":"6","key":"1096_CR34","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1073\/pnas.89.6.2115","volume":"89","author":"DF Bu","year":"1992","unstructured":"Bu DF, Erlander MG, Hitz BC, Tillakaratne NJ, Kaufman DL, Wagner-McPherson CB et al (1992) Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci USA 89(6):2115\u20132119","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"1096_CR35","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archpsyc.57.11.1061","volume":"57","author":"A Guidotti","year":"2000","unstructured":"Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR et al (2000) Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry. 57(11):1061\u20131069","journal-title":"Arch Gen Psychiatry."},{"issue":"6","key":"1096_CR36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archpsyc.59.6.521","volume":"59","author":"S Heckers","year":"2002","unstructured":"Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes FM (2002) Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch Gen Psychiatry. 59(6):521\u2013529","journal-title":"Arch Gen Psychiatry."},{"key":"1096_CR37","unstructured":"Woo T-UW, Walsh JP, Benes FM (2004) Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-d-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 61(7):649\u2013657"},{"issue":"2\u20133","key":"1096_CR38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.schres.2004.02.017","volume":"72","author":"SH Fatemi","year":"2005","unstructured":"Fatemi SH, Hossein Fatemi S, Stary JM, Earle JA, Araghi-Niknam M, Eagan E (2005) GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum. Schizophr Res. 72(2\u20133):109\u2013122","journal-title":"Schizophr Res."},{"issue":"11","key":"1096_CR39","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jpsychires.2009.02.005","volume":"43","author":"M Thompson","year":"2009","unstructured":"Thompson M, Weickert CS, Wyatt E, Webster MJ (2009) Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders. J Psychiatr Res. 43(11):970\u2013977","journal-title":"J Psychiatr Res."},{"issue":"1","key":"1096_CR40","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ajmg.b.30137","volume":"135B","author":"MD Lundorf","year":"2005","unstructured":"Lundorf MD, Buttensch\u00f8n HN, Foldager L, Blackwood DHR, Muir WJ, Murray V et al (2005) Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 135B(1):94\u2013101","journal-title":"Am J Med Genet B Neuropsychiatr Genet."},{"key":"1096_CR41","doi-asserted-by":"crossref","unstructured":"Chung Y-CE, Chen S-C, Chuang L-C, Shih W-L, Chiu Y-H, Lu M-L et al (2017) Evaluation of the interaction between genetic variants of GAD1 and miRNA in bipolar disorders. J Affect Disord 223:1\u20137","DOI":"10.1016\/j.jad.2017.07.024"},{"issue":"8","key":"1096_CR42","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/npp.2010.35","volume":"35","author":"S Marenco","year":"2010","unstructured":"Marenco S, Savostyanova AA, van der Veen JW, Geramita M, Stern A, Barnett AS et al (2010) Genetic modulation of GABA levels in the anterior cingulate cortex by GAD1 and COMT. Neuropsychopharmacology. 35(8):1708\u20131717","journal-title":"Neuropsychopharmacology."},{"issue":"Suppl 1","key":"1096_CR43","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/sj.mp.4001021","volume":"7","author":"JH Krystal","year":"2002","unstructured":"Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G et al (2002) Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry. 7(Suppl 1):S71\u201380","journal-title":"Mol Psychiatry."},{"issue":"3","key":"1096_CR44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0278-5846(82)80172-3","volume":"6","author":"E Mesdjian","year":"1982","unstructured":"Mesdjian E, Ciesielski L, Valli M, Bruguerolle B, Jadot G, Bouyard P et al (1982) Sodium valproate: kinetic profile and effects on GABA levels in various brain areas of the rat. Prog Neuropsychopharmacol Biol Psychiatry. 6(3):223\u2013233","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"issue":"669","key":"1096_CR45","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neulet.2016.06.045","volume":"16","author":"C Pisanu","year":"2018","unstructured":"Pisanu C, Papadima EM, Del Zompo M, Squassina A (2018) Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: potential involvement of epigenetics. Neurosci Lett. 16(669):24\u201331","journal-title":"Neurosci Lett."},{"issue":"9","key":"1096_CR46","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jpsychires.2008.12.006","volume":"43","author":"DP Gavin","year":"2009","unstructured":"Gavin DP, Kartan S, Chase K, Jayaraman S, Sharma RP (2009) Histone deacetylase inhibitors and candidate gene expression: an in vivo and in vitro approach to studying chromatin remodeling in a clinical population. J Psychiatr Res. 43(9):870\u2013876","journal-title":"J Psychiatr Res."},{"key":"1096_CR47","first-page":"1","volume-title":"Structured clinical interview for DSM-IV axis I disorders SCID-I","author":"MB First","year":"1996","unstructured":"First MB, Spitzer RL, Williams JB (1996) Structured clinical interview for DSM-IV axis I disorders SCID-I. American Psychiatric Press, Washington, DC, p 1"},{"key":"1096_CR48","unstructured":"DSM-IV PATFO (2000) Diagnostic and statistical manual of mental disorders: DSM-IV-TR. American Psychiatric Publishing, Inc, Washington, DC"},{"issue":"3","key":"1096_CR49","doi-asserted-by":"publisher","first-page":"CD006748","DOI":"10.1002\/14651858.CD006748.pub2","volume":"2009","author":"MT Moreira","year":"2009","unstructured":"Moreira MT, Smith LA, Foxcroft D (2009) Social norms interventions to reduce alcohol misuse in university or college students. Cochrane Database Syst Rev 2009(3):CD006748. https:\/\/doi.org\/10.1002\/14651858.CD006748.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1096_CR50","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry. 133:429\u2013435","journal-title":"Br J Psychiatry."},{"issue":"4","key":"1096_CR51","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","volume":"6","author":"M Hamilton","year":"1967","unstructured":"Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 6(4):278\u2013296","journal-title":"Br J Soc Clin Psychol."},{"key":"1096_CR52","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22\u201333 (quiz 34\u201357)"},{"issue":"2","key":"1096_CR53","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/nbm.1027","volume":"19","author":"RF Schulte","year":"2006","unstructured":"Schulte RF, Lange T, Beck J, Meier D, Boesiger P (2006) Improved two-dimensional J-resolved spectroscopy. NMR Biomed. 19(2):264\u2013270","journal-title":"NMR Biomed."},{"issue":"4","key":"1096_CR54","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G","volume":"41","author":"I Tk\u00e1c","year":"1999","unstructured":"Tk\u00e1c I, Starcuk Z, Choi IY, Gruetter R (1999) In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med. 41(4):649\u2013656","journal-title":"Magn Reson Med."},{"issue":"2","key":"1096_CR55","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/mrm.24703","volume":"71","author":"A Fuchs","year":"2013","unstructured":"Fuchs A, Boesiger P, Schulte RF, Henning A (2013) ProFit revisited. Magn Reson Med. 71(2):458\u2013468","journal-title":"Magn Reson Med."},{"issue":"2","key":"1096_CR56","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/nbm.1026","volume":"19","author":"RF Schulte","year":"2006","unstructured":"Schulte RF, Boesiger P (2006) ProFit: two-dimensional prior-knowledge fitting of J-resolved spectra. NMR Biomed. 19(2):255\u2013263","journal-title":"NMR Biomed."},{"issue":"6","key":"1096_CR57","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","volume":"30","author":"SWS Provencher","year":"1993","unstructured":"Provencher SWS (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 30(6):672\u2013679","journal-title":"Magn Reson Med."},{"issue":"1","key":"1096_CR58","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/mrm.1910060111","volume":"6","author":"JW van der Veen","year":"1988","unstructured":"van der Veen JW, de Beer R, Luyten PR, van Ormondt D (1988) Accurate quantification of in vivo 31P NMR signals using the variable projection method and prior knowledge. Magn Reson Med. 6(1):92\u201398","journal-title":"Magn Reson Med."},{"key":"1096_CR59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1006\/jmra.1994.1008","volume":"106","author":"SA Smith","year":"1994","unstructured":"Smith SA, Levante TO, de Beer R, Luyten PR, van Ormondt D (1994) Computer simulations in magnetic resonance. An object-oriented programming approach. J Magn Reson A 106:75\u2013105. https:\/\/doi.org\/10.1006\/jmra.1994.1008","journal-title":"J Magn Reson A"},{"key":"1096_CR60","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0079-6565(95)01017-3","volume":"28","author":"T Fan","year":"1996","unstructured":"Fan T (1996) Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures. Prog Nucl Mag Reson Spectrosc. 28:161\u2013219","journal-title":"Prog Nucl Mag Reson Spectrosc."},{"issue":"3","key":"1096_CR61","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V","volume":"13","author":"V Govindaraju","year":"2000","unstructured":"Govindaraju V, Young K, Maudsley AA (2000) Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 13(3):129\u2013153","journal-title":"NMR Biomed."},{"issue":"6","key":"1096_CR62","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/mrm.20901","volume":"55","author":"C Gasparovic","year":"2006","unstructured":"Gasparovic C, Song T, Devier D, Bockholt HJ, Caprihan A, Mullins PG et al (2006) Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn Reson Med. 55(6):1219\u20131226","journal-title":"Magn Reson Med."},{"issue":"5","key":"1096_CR63","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/nbm.713","volume":"14","author":"V Mlyn\u00e1rik","year":"2001","unstructured":"Mlyn\u00e1rik V, Gruber S, Moser E (2001) Proton T (1) and T (2) relaxation times of human brain metabolites at 3 Tesla. NMR Biomed. 14(5):325\u2013331","journal-title":"NMR Biomed."},{"issue":"1","key":"1096_CR64","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1109\/42.906424","volume":"20","author":"Y Zhang","year":"2001","unstructured":"Zhang Y, Brady M, Smith S (2001) Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging. 20(1):45\u201357","journal-title":"IEEE Trans Med Imaging."},{"issue":"4","key":"1096_CR65","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/nbm.701","volume":"14","author":"S Cavassila","year":"2001","unstructured":"Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D (2001) Cram\u00e9r-Rao bounds: an evaluation tool for quantitation. NMR Biomed. 14(4):278\u2013283","journal-title":"NMR Biomed."},{"key":"1096_CR66","unstructured":"Laitinen J, Samarut J, H\u00f6ltt\u00e4 E (1994) A nontoxic and versatile protein salting-out method for isolation of DNA. Biotechniques 17(2):316\u2013322"},{"issue":"1","key":"1096_CR67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0893-133X(01)00225-1","volume":"25","author":"FM Benes","year":"2001","unstructured":"Benes FM, Berretta S (2001) GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology. 25(1):1\u201327","journal-title":"Neuropsychopharmacology."},{"key":"1096_CR68","first-page":"365","volume":"9","author":"MK Brix","year":"2015","unstructured":"Brix MK, Ersland L, Hugdahl K, Gr\u00fcner R, Posserud M-B, Hammar \u00c5 et al (2015) Brain MR spectroscopy in autism spectrum disorder-the GABA excitatory\/inhibitory imbalance theory revisited. Front Hum Neurosci. 9:365","journal-title":"Front Hum Neurosci."},{"issue":"6","key":"1096_CR69","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1364-6613(00)01483-2","volume":"4","author":"G Bush","year":"2000","unstructured":"Bush G, Luu P, Posner M (2000) Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci (Regul Ed). 4(6):215\u2013222","journal-title":"Trends Cogn Sci (Regul Ed)."},{"key":"1096_CR70","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.neuro.25.112701.142754","volume":"25","author":"DA Lewis","year":"2002","unstructured":"Lewis DA, Levitt P (2002) Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci. 25:409\u2013432","journal-title":"Annu Rev Neurosci."},{"issue":"4","key":"1096_CR71","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/mp.2017.73","volume":"23","author":"DP Hibar","year":"2018","unstructured":"Hibar DP, Westlye LT, Doan NT, Jahanshad N, Cheung JW, Ching CRK et al (2018) Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Mol Psychiatry\u00a023(4):932\u2013942. https:\/\/doi.org\/10.1038\/mp.2017.73","journal-title":"Mol Psychiatry"},{"issue":"4","key":"1096_CR72","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1176\/appi.ajp.159.4.663","volume":"159","author":"G Sanacora","year":"2002","unstructured":"Sanacora G, Mason GF, Rothman DL, Krystal JH (2002) Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry. 159(4):663\u2013665","journal-title":"Am J Psychiatry."},{"key":"1096_CR73","unstructured":"Stahl SM (2009) The Prescriber's Guide, antipsychotics and mood stabilizers. Cambridge University Press, Cambridge"},{"issue":"2","key":"1096_CR74","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0306-4522(99)00468-6","volume":"95","author":"MO Cunningham","year":"2000","unstructured":"Cunningham MO, Dhillon A, Wood SJ, Jones RS (2000) Reciprocal modulation of glutamate and GABA release may underlie the anticonvulsant effect of phenytoin. Neuroscience 95(2):343\u2013351","journal-title":"Neuroscience"},{"issue":"5","key":"1096_CR75","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.biopsych.2004.06.012","volume":"56","author":"SD Friedman","year":"2004","unstructured":"Friedman SD, Dager SR, Parow A, Hirashima F, Demopulos C, Stoll AL et al (2004) Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biol Psychiatry. 56(5):340\u2013348","journal-title":"Biol Psychiatry."},{"issue":"4","key":"1096_CR76","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1034\/j.1399-5618.2003.00024.x","volume":"5","author":"E Scarr","year":"2003","unstructured":"Scarr E, Pavey G, Sundram S, MacKinnon A, Dean B (2003) Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder. Bipolar Disord. 5(4):257\u2013264","journal-title":"Bipolar Disord."},{"issue":"9","key":"1096_CR77","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.npp.1301312","volume":"32","author":"M Beneyto","year":"2007","unstructured":"Beneyto M, Kristiansen LV, Oni-Orisan A, McCullumsmith RE, Meador-Woodruff JH (2007) Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology. 32(9):1888\u20131902","journal-title":"Neuropsychopharmacology."},{"key":"1096_CR78","first-page":"119","volume":"8","author":"N Goto","year":"2012","unstructured":"Goto N, Yoshimura R, Kakeda S, Nishimura J, Moriya J, Hayashi K et al (2012) Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia. Neuropsychiatr Dis Treat. 8:119\u2013122","journal-title":"Neuropsychiatr Dis Treat."},{"issue":"5","key":"1096_CR79","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00540-011-1199-z","volume":"25","author":"J Luo","year":"2011","unstructured":"Luo J, Min S, Wei K, Li P, Dong J, Liu Y-F (2011) Propofol protects against impairment of learning-memory and imbalance of hippocampal Glu\/GABA induced by electroconvulsive shock in depressed rats. J Anesth. 25(5):657\u2013665","journal-title":"J Anesth."},{"issue":"3","key":"1096_CR80","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/appi.ajp.160.3.577","volume":"160","author":"G Sanacora","year":"2003","unstructured":"Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB et al (2003) Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry. 160(3):577\u2013579","journal-title":"Am J Psychiatry."},{"issue":"2","key":"1096_CR81","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/bdi.12733","volume":"21","author":"LV Kessing","year":"2019","unstructured":"Kessing LV (2019) What is early intervention in bipolar disorder? Recommendation of a pragmatic way focusing on early intervention in patients with newly diagnosed bipolar disorder. Bipolar Disord\u00a021(2):168\u2013169. https:\/\/doi.org\/10.1111\/bdi.12733","journal-title":"Bipolar Disord"},{"issue":"9","key":"1096_CR82","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0706743716659417","volume":"61","author":"SH Kennedy","year":"2016","unstructured":"Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P et al (2016) Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major Depressive Disorder: Section 3. Pharmacological Treatments. Can J Psychiatry. 61(9):540\u2013560","journal-title":"Can J Psychiatry."}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-020-01096-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-020-01096-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-020-01096-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T12:05:01Z","timestamp":1616241901000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-020-01096-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,28]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1096"],"URL":"https:\/\/doi.org\/10.1007\/s00406-020-01096-0","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,28]]},"assertion":[{"value":"23 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors report biomedical financial interests or potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}